Evidence map›Paper›PMID 39769270›Full record

ArticleInternational journal of molecular sciences2024

Circadian Effects of Melatonin Receptor-Targeting Molecules In Vitro.

Kaitlyn Chhe, Maya S Hegde, Stephanie R Taylor, Michelle E Farkas

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kaitlyn ChheDepartment of Chemistry, University of Massachusetts Amherst, Amherst, MA 01003, USA.ORCID 0009-0000-2165-9283
Maya S HegdeDepartment of Biochemistry and Molecular Biology, University of Massachusetts Amherst, Amherst, MA 01003, USA.
Stephanie R TaylorDepartment of Computer Science, Colby College, Waterville, ME 04901, USA.ORCID 0000-0003-3562-6479
Michelle E FarkasDepartment of Chemistry, University of Massachusetts Amherst, Amherst, MA 01003, USA.

Funding

Chemical Biology Approaches for Studying Circadian RhythmsR35GM143016 · NIGMS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI FARKAS, MICHELLE ELIZABETH · 2021 to 2025
$1.9M
NIGMS NIH HHS R35 GM143016NIH HHS 1R35GM143016-03A1
6 · The paper itself

Abstract

Circadian rhythms are important for maintaining homeostasis, from regulating physiological activities (e.g., sleep-wake cycle and cognitive performance) to cellular processes (e.g., cell cycle and DNA damage repair). Melatonin is a key regulator of circadian rhythms and exerts control by binding to melatonin receptor 1 (MT1), decreasing neuronal firing in the suprachiasmatic nucleus (SCN). Previous work studying effects of melatonin on circadian rhythms utilized in vivo models. Since MT1 is also expressed outside of the brain, it is important to study impacts of melatonin on circadian gene oscillations in vitro. We evaluated the effects of melatonin and an MT1 inverse agonist, UCSF7447, in U2OS circadian reporter cell lines, which facilitate detailed assessments of oscillatory changes. We report that cellular circadian rhythms are responsive to treatment with MT1-targeting molecules; their activities are not dependent upon the SCN. Corroborating in vivo data, both melatonin and UCSF7447 lengthened the periods of

Indexed as

ARNTL Transcription FactorsCircadian RhythmMelatoninPeriod Circadian ProteinsReceptor, Melatonin, MT1AnimalsCell Line, TumorHumansSuprachiasmatic NucleusARNTL Transcription FactorsBMAL1 protein, humanMelatoninPER2 protein, humanPeriod Circadian ProteinsReceptor, Melatonin, MT1bioluminescent reportersBMAL1cell culture modelscircadian rhythmmelatoninPER2period changephase shiftU2OS cells

Identifiers

PMID39769270
PMCPMC11727910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.